Measles and rubella monitoring – January 2017
The ECDC measles and rubella monitoring report is published twice a year. The January issue reports on the previous calendar year, while the July issue focuses on the most recent measles and rubella season and presents the data collected over the past 12 months.
WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season
The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.
Surveillance of invasive bacterial diseases in Europe, 2012
This report describes the occurrence of invasive bacterial diseases (IBD) in Europe during 2012, based on data collected through The European Surveillance System (TESSy).
ECDC Annual Influenza Meeting, 2017
The annual influenza meeting focused on new developments in influenza surveillance at the country and regional level, seasonal influenza vaccination programmes, provided an update on the global situation with regard to outbreaks of avian influenza and other emerging respiratory pathogens, and provided a forum for exchanging experiences from the past influenza season.
Reliable surveillance of tick-borne encephalitis in European countries is necessary to improve the quality of vaccine recommendationsArchived
In July–November 2009, 26 European Union Member States, Norway and Iceland, participated in a survey seeking information on national tick-borne encephalitis (TBE) vaccination recommendations.
Mumps Complications and Effects of Mumps Vaccination, England and Wales, 2002–2006Archived
The authors analyzed data from hospital admissions and enhanced mumps surveillance to assess mumps complications during the largest mumps outbreak in England and Wales, 2004–2005, and their association with mumps vaccination. When compared with non-outbreak periods, the outbreak was associated with a clear increase in hospitalized patients with orchitis, meningitis and pancreatitis. Routine mumps surveillance and hospital data showed that 6.1% of mumps patients were hospitalized, 4.4% had orchitis, 0.35% meningitis and 0.33% pancreatitis.